Granted Patent B2

US 12,544,072 · App. 17/412,360 · Granted Feb 10, 2026

Inventors: Fiona M. Sander (Los Altos Hills, CA); Michael P. Allen (Los Altos, CA); Mattew Yurek (San Diego, CA); Kenneth F. Binmoeller (San Francisco, CA)

Assignee: Boston Scientific Scimed, Inc.

A61B17/1114A61B17/11A61B17/12009A61B17/3468A61M25/1002A61B2017/00004A61B2017/00278A61B2017/0034A61B2017/00867A61B2017/1103A61B2017/1139A61B17/3478A61B2017/3486A61F2/82A61M2025/0096A61M2025/09125A61M2025/1059

Abstract

Claims (30)

1 . A medical device, comprising:

a body formed of a filament braid, the body having an unconstrained configuration and a constrained configuration, the body having a first end, a second end, and a central region extending therebetween, wherein, in the unconstrained configuration, the first end radially expands into a flange structure and the central region expands into a saddle region, establishing a fluid flow path therethrough, wherein a length of the body in the unconstrained configuration is at least 70% less than a length of the body in the constrained configuration, wherein the flange structure includes an atraumatic tissue apposing surface adjacent to the saddle region, and wherein the atraumatic tissue apposing surface comprises a double-ringed flange structure having a pair of adjacent annular rings that face each other,

wherein the saddle region is extensible to reduce trauma from the flange tissue apposing surface, and

wherein the flange structure has an open end at least as great as a diameter of the saddle region.

2 . The medical device of claim 1 , wherein the flange structure has a diameter that is at least substantially 1.5 times the diameter of the saddle region.

3 . The medical device of claim 1 , wherein the flange structure includes a wall that is aligned substantially perpendicular to a longitudinal axis of the saddle region when in the unconstrained configuration.

4 . The medical device of claim 1 , wherein at least the saddle region comprises a covering.

5 . The medical device of claim 1 , wherein a diameter of the flange structure ranges from 5 mm to 40 mm in the unconstrained configuration.

6 . The medical device of claim 1 , wherein the flange structure is formed from a singular tubular structure of the filament braid.

7 . A drainage stent, comprising:

a body formed of a filament braid, the body having an unconstrained configuration and a constrained configuration, the body having a first end, a second end, and a central region configured therebetween, and the body in the unconstrained configuration configured to form a fluid drainage path;

wherein, in the unconstrained configuration, the first end radially expands into a flange structure and the central region expands into a saddle region;

wherein the flange structure has a diameter that is at least substantially 1.5 times the diameter of the saddle region;

wherein the flange structure includes an atraumatic tissue apposing surface adjacent to the saddle region, and wherein the atraumatic tissue apposing surface comprises a double-ringed flange structure having a pair of adjacent annular rings that face each other,

wherein the saddle region is extensible to reduce trauma from the flange tissue apposing surface, wherein the flange structure has an open end at least as great as the diameter of the saddle region, and

wherein a length of the body in the unconstrained configuration is at least 70% less than a length of the body in the constrained configuration.

8 . The drainage stent of claim 7 , wherein the flange structure includes a wall that is aligned substantially perpendicular to a longitudinal axis of the saddle region when in the unconstrained configuration.

9 . The drainage stent of claim 7 , wherein at least the saddle region comprises a covering.

10 . The drainage stent of claim 7 , wherein a diameter of the flange structure ranges from 5 mm to 40 mm in the unconstrained configuration.

11 . A drainage stent, comprising:

a body formed of a filament braid, the body having an unconstrained configuration and a constrained configuration, the body having a first end, a second end, and a central region configured therebetween, and the body in the unconstrained configuration configured to form a drainage path therethrough;

wherein, in the unconstrained configuration, the first end radially expands into a flanged retention structure, the second end radially expands into a retention region, and the central region expands into a saddle region extending therebetween;

wherein the flanged retention structure has a diameter that is at least substantially 1.5 times the diameter of the saddle region;

wherein the flanged retention structure includes an atraumatic tissue apposing surface adjacent to the saddle region, and wherein the atraumatic tissue apposing surface comprises a double-ringed flange structure having a pair of adjacent annular rings that face each other,

wherein the saddle region is extensible to reduce trauma from the flange tissue apposing surface, wherein the flanged retention structure has an open end at least as great as the diameter of the saddle region, and

wherein a length of the body in the unconstrained configuration is at least 70% less than a length of the body in the constrained configuration.

12 . The drainage stent of claim 11 , wherein each of the flanged retention structure and the retention region are formed from a singular tubular structure.

13 . The drainage stent of claim 11 , wherein the retention region has an open end at least as great as the diameter of the saddle region.

14 . The drainage stent of claim 11 , wherein the diameter of the flanged retention structure is greater than twice a diameter of the saddle region in the unconstrained configuration.

15 . The drainage stent of claim 11 , wherein at least the saddle region comprises a covering.

Assignments (3)

Continuity (7)

References Cited (400)